Find Faculty

Nitin Barman, MD

img_Nitin Barman
ASSISTANT PROFESSOR | Medicine, Cardiology
212-523-2400
email
Are you a patient?
View my
Provider Profile
Specialties
Cardiovascular Disease (Heart Disease), Interventional Cardiology, Cardiology (Heart)

MD, University of Chicago Pritzker School of Medicine

Residency, Internal Medicine, University of California San Francisco

Fellowship, Cardiology, Cleveland Clinic Foundation

Fellowship, Interventional Cardiology, Mount Sinai Hospital

Certifications

American Board of Internal Medicine
57
Publications

Selected Publications

Lessons learned from the feasibility phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) trial program. Mario Gaudino, Gregg W. Stone, John Puskas, Katherine Krieger, Bjorn Redfors, Emilia Bagiella, Annetine Gelijns, Deepak L. Bhatt, Sigrid Sandner, Nitin Barman, John Bozinovski, Patrick Gee, Ali Haider, Abdul Moiz Hafiz, Sanjit S. Jolly, Ditian Li, Charles Mack, Michael M. Madani, Ehtisham Mahmud, Andres M. Pineda, Frederick A. Masoudi, Ernest Mazzaferri, Rhonda Monroe, William Nicholson, Stuart J. Pocock, Rajesh Sachdeva, Celina Yong, Brittany A. Zwischenberger, Clyde Yancy, Ruth Masterson Creber, John Spertus. American Heart Journal

AI-enhanced recognition of occlusions in acute coronary syndrome (AERO-ACS): a retrospective study. James W.H. Choi, Vincent Torelli, Alex Silverman, Sara Saravia Diaz, Darren Kong, Esha Vaish, Luka Katic, Alex Nagourney, Zara Khan, Lexi Robbins, Sean Pinney, Nitin Barman, Serdar Farhan. Coronary Artery Disease

Long-Term Clinical Outcomes of Treatments for In-Stent Chronic Total Occlusions: A Real-World Study Based on Different Strategies of Revascularization. Zhuoran Yang, Jiasheng Yin, Yiqing Hu, Li Zhu, You Zhou, Yaqi Zhang, Nirupama Krishnamurthi, Jieyu Jiang, Wenxian Zhou, Nitin Barman, Hao Lu, Junbo Ge. MedComm - Future Medicine

View All Publications

Mount Sinai Morningside

440 West 114th Street, 2nd Floor ,Suite 220

New York, NY 10025

212-523-2400

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Barman has not yet completed reporting of industry relationships or has no industry relationships to report.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.